BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Adipose tissue
,
DNA fingerprint
,
Trichostatin A
,
rs2230926
,
PPARA
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
response to anticoagulant
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon cecum
Vena cava
Stomach fundus
Mammary gland
Thymus gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Dermatosis due to mites
Myocardial ischemia
Fibrosis of lung
Klinefelter's syndrome, XXY
Immunoglobulin G4 deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
chiron
Pluronic F68
ischemin
PCI 24781
Arachidonic Acid
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
491333
Scd1
SPIB
EDA
DIDO1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for response to anticoagulant
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial F…
Determinants of Oral Anticoagulants' Activity
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rap…
OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Tr…
EXCOR® Pediatric VAD Anticoagulation IDE
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ